Re: Results of investigation into statin side effects due by end of year. BMJ 2015; 350.

I am looking forward to reviewing the results of the ongoing investigation by Collins and colleagues (i.e., The Cholesterol Treatment Trials Collaboration).

My investigation will be also due by the end of the year.(1)

Goodbye PubMed, hello raw data (i.e., figshare).(2,3)

References

1. Ramirez, Jorge H (2014): The pharmacology of statins in humans: a critical analysis. figshare.
http://dx.doi.org/10.6084/m9.figshare.1157386

2. Godlee Fiona. Goodbye PubMed, hello raw data BMJ 2011; 342 :d212.

3. Re: Novo Nordisk replies to BMJ investigation on incretins and pancreatic damage. BMJ 2013;347:f4386. URL: http://www.bmj.com/content/347/bmj.f4386/rr/763130 (Date: August 22, 2014)

Competing interests: Non-financial: http://chaoticpharmacology.com/disclaimer-coi/

Read the original response on The BMJhttp://www.bmj.com/content/350/bmj.h957/rr-0

  1 comment for “Re: Results of investigation into statin side effects due by end of year. BMJ 2015; 350.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: